Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BYFrontiers in Medicine

The cartilage endplate in intervertebral disc degeneration: a review of physiological functions, failure mechanisms, and clinical relevance

  1. 1First Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
  2. 2Second Clinical Medical College, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China
  3. 3Fourth Department of Orthopedics, The First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang, China

Abstract

Intervertebral disc degeneration (IVDD) can contribute to low back pain, although imaging evidence of degeneration does not by itself identify a symptomatic spinal level. The cartilage endplate (CEP), situated between the intervertebral disc and the bony vertebral endplate, contributes to solute transport, load transfer, and maintenance of the nucleus pulposus tissue boundary. This review examines CEP physiology, structural and functional abnormalities, experimental mechanisms, and current clinical relevance. Human tissue and imaging studies have identified focal CEP abnormalities and associations with disc degeneration. Ex vivo, cell, and animal studies further suggest that altered nutrient and lactate exchange, abnormal loading, inflammation, oxidative stress, dysregulated autophagy, and ferroptosis may contribute to interactions between the CEP and adjacent disc tissues. These findings, however, do not establish the temporal sequence or clinical importance of these processes in patients. Conventional magnetic resonance imaging and computed tomography primarily depict the disc, bony endplate, and adjacent vertebral marrow; Modic changes are marrow abnormalities rather than direct measures of CEP degeneration. Ultrashort echo time and volumetric interpolated breath-hold examination imaging may improve assessment of CEP morphology, whereas dynamic contrast-enhanced and loaded imaging provide indirect information about the broader endplate region. Direct CEP imaging remains investigational because of limited standardization, histological validation, and longitudinal evidence. No CEP-specific imaging or molecular marker has been validated to independently localize a pain-generating level or guide treatment selection, and its prognostic value beyond established clinical and imaging measures remains incompletely established. Current evidence supports a testable model in which dysfunction of the CEP–nucleus pulposus interface may contribute to and amplify IVDD. Whether CEP abnormalities initiate degeneration, amplify an established process, or arise secondarily remains unresolved in humans.

Related

  1. Investigating potential molecular mechanisms linking 6PPD-quinone exposure to Intervertebral Disc Degeneration: A network toxicology, molecular docking, and molecular dynamics simulation study
    Bin Yang, Xiangjin Wang, Li Zhuo +2
    PLOS OnePeer-reviewedCC BYFull textCell biologyImmunologyPLOSEurope PMC
  2. Ferroptosis in Intervertebral Disc Degeneration: How the Extreme Microenvironment Rewires a Cell Death Network
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Dual‐Gene Edited Extracellular Vesicles Remodel the Redox Homeostasis to Inhibit Ferroptosis in Intervertebral Disc Degeneration
    Jing Yan, Yazhou Lin, Shuo Miao +8
    Advanced SciencePeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  4. Microenvironment‐Responsive Biomimetic Hydrogels Delivering Cistanche Deserticola‐Derived Nanovesicles for Intervertebral Disc Degeneration
    Ning Xu, Xiaoyu Cai, Xiaofu Tang +9
    Advanced SciencePeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  5. pH/ROS dual-responsive SmartGel-Cas9/TRPV4 for autophagy regulation in intervertebral disc degeneration
    Xiao-Jun Yu, Bing-Yao Quan, Peng Zou +5
    Materials Today BioPeer-reviewedCC BY-NC 4.0Full textSurgery & anaesthesiaPMC
BibTeX
@article{xie2026cartilage,
  title = {{The cartilage endplate in intervertebral disc degeneration: a review of physiological functions, failure mechanisms, and clinical relevance}},
  author = {Xi Xie and Haotian Zheng and Guang Gan and Changyu Xiao and Wenjing Zhu and Yonghan Liu and Chen Li and Xi Gao},
  journal = {Frontiers in Medicine},
  year = {2026},
  month = nov,
  doi = {10.3389/fmed.2026.1963585},
  url = {https://doi.org/10.3389/fmed.2026.1963585},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - The cartilage endplate in intervertebral disc degeneration: a review of physiological functions, failure mechanisms, and clinical relevance
AU  - Xi Xie
AU  - Haotian Zheng
AU  - Guang Gan
AU  - Changyu Xiao
AU  - Wenjing Zhu
AU  - Yonghan Liu
AU  - Chen Li
AU  - Xi Gao
PY  - 2026
DA  - 2026/11/16
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2026.1963585
UR  - https://doi.org/10.3389/fmed.2026.1963585
AB  - Intervertebral disc degeneration (IVDD) can contribute to low back pain, although imaging evidence of degeneration does not by itself identify a symptomatic spinal level. The cartilage endplate (CEP), situated between the intervertebral disc and the bony vertebral endplate, contributes to solute transport, load transfer, and maintenance of the nucleus pulposus tissue boundary. This review examines CEP physiology, structural and functional abnormalities, experimental mechanisms, and current clinical relevance. Human tissue and imaging studies have identified focal CEP abnormalities and associations with disc degeneration. Ex vivo, cell, and animal studies further suggest that altered nutrient and lactate exchange, abnormal loading, inflammation, oxidative stress, dysregulated autophagy, and ferroptosis may contribute to interactions between the CEP and adjacent disc tissues. These findings, however, do not establish the temporal sequence or clinical importance of these processes in patients. Conventional magnetic resonance imaging and computed tomography primarily depict the disc, bony endplate, and adjacent vertebral marrow; Modic changes are marrow abnormalities rather than direct measures of CEP degeneration. Ultrashort echo time and volumetric interpolated breath-hold examination imaging may improve assessment of CEP morphology, whereas dynamic contrast-enhanced and loaded imaging provide indirect information about the broader endplate region. Direct CEP imaging remains investigational because of limited standardization, histological validation, and longitudinal evidence. No CEP-specific imaging or molecular marker has been validated to independently localize a pain-generating level or guide treatment selection, and its prognostic value beyond established clinical and imaging measures remains incompletely established. Current evidence supports a testable model in which dysfunction of the CEP–nucleus pulposus interface may contribute to and amplify IVDD. Whether CEP abnormalities initiate degeneration, amplify an established process, or arise secondarily remains unresolved in humans.
SN  - 2296-858X
ER  -